Micro Emerging Active

Allogene Therapeutics analyst sentiment

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
3
Sources
1

Sentiment Timeline

Event Timeline

May 02, 2026
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock Neutral
Apr 24, 2026
H.C. Wainwright Maintains Buy Rating on Allogene Therapeutics (ALLO) Bullish
Apr 12, 2026
Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)? Neutral

Timeline

Last UpdatedApr 12, 2026